Skip to content

Restricted Cash at other companies

NAG
Niagen Bioscience, Inc. Common StockNAGE
$152K0.0%
BellRing Brands logo
BellRing BrandsBRBR
$600K-96.3%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$0-100%
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
$0
Bark, Inc. logo
Bark, Inc.BARK
$5.47M+15.7%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's restricted cash?
USANA Health Sciences (USNA) reported restricted cash of $2.91M in Q1 2026.
How has USANA Health Sciences's restricted cash changed year-over-year?
USANA Health Sciences's restricted cash increased by 5.5% year-over-year, from $2.75M to $2.91M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.